|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| (11) | Number of the document | 3395818 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18167649.5 |
| Date of filing the European patent application | 2015-08-03 | |
| (97) | Date of publication of the European application | 2018-10-31 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-22 |
| (46) | Date of publication of the claims translation | 2021-11-25 |
| (30) | Number | Date | Country code |
| 14179692 | 2014-08-04 | EP | |
| 15159342 | 2015-03-17 | EP |
| (72) |
WORTMANN, Lars , DE
LÜCKING, Ulrich , DE
LEFRANC, Julien , DE
BRIEM, Hans , DE
KOPPITZ, Marcus , DE
EIS, Knut , DE
VON NUSSBAUM, Franz , DE
BADER, Benjamin , DE
WENGNER, Antje-Margret , DE
SIEMEISTER, Gerhard , DE
BONE, Wilhelm , DE
LIENAU, Philip , DE
GRUDZINSKA-GOEBEL, Joanna , DE
MOOSMAYER, Dieter , DE
EBERSPÄCHER, Uwe , DE
SCHICK, Hans , DE
|
| (73) |
Bayer Pharma Aktiengesellschaft ,
Müllerstrasse 178, 13353 Berlin,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | 2-(Morfolin-4-il)-1,7-naftiridinai |
| 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES |
| Payment date | Validity (years) | Amount | |
| 2023-07-19 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-08-03 |